Preclinical toxicity study radioactive tracer
This tender concerns the execution of a standardized preclinical toxicity study for a new radiopharmaceutical by a certified laboratory. The award takes place on the basis of the lowest price.
Services · Open · European procedure
01What is being requested
Execution of a preclinical toxicity study in accordance with EMA guidelines for a new radiopharmaceutical. The assignment includes an extended single dose toxicity study, an MTD study with 3 doses, a cytokine release study and an antibody cross reactivity study, with reporting no later than 31 October 2026.
The purpose of this Tender is to contract 1 Entrepreneur for the execution of a toxicity study in accordance with EMA guidelines (ICH-M3(R2)).
02Strategic insight
Ensure that the laboratory complies with strict GLP and AAALAC certifications. Because the award is based solely on the lowest price, a sharp price quotation is essential. Check whether all mandatory attachments are submitted exactly according to the requested filename.
03Points of attention
04Can I take part?
05Exclusion grounds
- No specific exclusion grounds were extracted. In a European tender, the mandatory and discretionary grounds of art. 2.86/2.87 of the Dutch Procurement Act almost always apply — check the European Single Procurement Document (ESPD).
06Award criteria
The award will be made to the most economically advantageous tender on the basis of the lowest price, as the assignment consists of standardized studies with fully determined content and methodology.
07Process & timeline
08Value in context
The contracting authority did not publish an estimated value — common for a large share of contracts. The EU threshold for diensten is € 221.000, for reference.
09Likely competitors
10Tender documents
11Legal themes that may be relevant here
12Frequently asked questions
What is the purpose of the assignment?
Which specific guidelines must the research comply with?
Automatically compiled from the official tender data and documents.
13Estimated value versus the market
€ 165K
€ 413K
€ 1,0 mln
Gegunde waarden in CPV 73 · diensten n=468